Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy

Clinical trial NCT03345134 · NOT_YET_RECRUITING

Trial details

NCT number: NCT03345134
Sponsor: Shaheen Alanee
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma Endoscopic Surgical Procedure Transitional Epithelial Cells

Start date: 2017-11-30
Primary completion: 2021-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.